Pleural recurrence and long-term survival after thoracotomy and thoracoscopic lobectomy

Ann Thorac Surg. 2013 Nov;96(5):1769-75. doi: 10.1016/j.athoracsur.2013.05.037. Epub 2013 Aug 20.

Abstract

Background: There are concerns over procedure-related pleural dissemination during video-assisted thoracic surgery (VATS) lobectomy. We compared the incidence of pleural recurrence and long-term survival between patients undergoing thoracotomy and VATS lobectomy for non-small cell lung cancer (NSCLC) with visceral pleural invasion.

Methods: From 2004 to 2009, 2,774 patients underwent curative-intent pulmonary resection for NSCLC at our institution. Of those, 478 patients were pathologically confirmed to have visceral pleural invasion by primary tumor. Among these, 239 patients (50%) underwent VATS lobectomy and 239 (50%) underwent thoracotomy lobectomy. Their medical records were retrospectively reviewed and a propensity score-matched analysis was performed.

Results: Matching based on propensity scores produced 167 patients in each group. There were no significant differences between two groups in age, sex, histologic type, tumor size, and pathologic N stage. The median follow-up duration was 52 months. During follow-up, 14 patients (8.4%) from the VATS group and 12 (7.2%) from the thoracotomy group had ipsilateral pleural recurrence (p = 0.735). There was no significant difference in the recurrence pattern between the two groups. Overall survival at 5 years was 83% and 74% in the VATS and thoracotomy groups, respectively (p = 0.16). Disease-free survival at 5 years was 65% and 62% in the VATS and thoracotomy groups, respectively (p = 0.45).

Conclusions: Compared with thoracotomy, VATS lobectomy does not seem to increase the risk of procedure-related pleural dissemination in patients with NSCLC with visceral pleural invasion. Long-term survival and pattern of recurrence were similar between the two groups.

Keywords: 10.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Non-Small-Cell Lung / mortality*
  • Carcinoma, Non-Small-Cell Lung / surgery*
  • Female
  • Humans
  • Lung Neoplasms / mortality*
  • Lung Neoplasms / surgery*
  • Male
  • Middle Aged
  • Neoplasm Seeding*
  • Pleural Neoplasms / epidemiology*
  • Pneumonectomy / methods*
  • Retrospective Studies
  • Survival Rate
  • Thoracic Surgery, Video-Assisted*
  • Thoracoscopy*
  • Thoracotomy*
  • Time Factors